CLAYTON STARNES: Open Payments
NPI 1346854841 · MOORESVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,005 in 56 payments from 18 companies in 2025. Trend: 2023 $973 · 2024 $1,115 · 2025 $1,005
Food & beverage: $916Education: $89
| Company | Payments | Amount |
|---|---|---|
| Actelion Pharmaceuticals US, Inc. | 15 | $254 |
| Merck Sharp & Dohme LLC | 6 | $111 |
| Novartis Pharmaceuticals Corporation | 6 | $101 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $100 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $99 |
| SCPHARMACEUTICALS INC. | 3 | $51 |
| Amgen Inc. | 2 | $42 |
| CVRx, Inc. | 2 | $39 |
| E.R. Squibb & Sons, L.L.C. | 2 | $34 |
| Novo Nordisk Inc | 2 | $32 |
Products named: OPSUMIT, LEQVIO, JARDIANCE, Kerendia, VERQUVO, ELIQUIS, FUROSCIX, REPATHA.
Industry payments across NC — which companies pay providers there.
